Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

September 27, 2022; 99 (13) Research Article

Follow-up of Patients With Stroke Based on Opt-out Choice

Potential Approach for Acute Care Quality Registries or Observational Studies

View ORCID ProfileIra Napierkowski, Irina Lorenz-Meyer, Annegret Hille, Martin Ebinger, Erik Freitag, Peter Harmel, Matthias Endres, Georg Hagemann, Hans-Christian Koennecke, Bruno-Marcel Mackert, View ORCID ProfileBob Siegerink, Heinrich J. Audebert, on behalf of the Berlin–SPecific Acute Treatment in Ischemic or hAemorrhagic Stroke With Long Term Follow-up (B-SPATIAL) registry
First published August 2, 2022, DOI: https://doi.org/10.1212/WNL.0000000000200916
Ira Napierkowski
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ira Napierkowski
Irina Lorenz-Meyer
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annegret Hille
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Ebinger
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Freitag
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Harmel
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Endres
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg Hagemann
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Christian Koennecke
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno-Marcel Mackert
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bob Siegerink
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bob Siegerink
Heinrich J. Audebert
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
Full PDF
Short Form
Citation
Follow-up of Patients With Stroke Based on Opt-out Choice
Potential Approach for Acute Care Quality Registries or Observational Studies
Ira Napierkowski, Irina Lorenz-Meyer, Annegret Hille, Martin Ebinger, Erik Freitag, Peter Harmel, Matthias Endres, Georg Hagemann, Hans-Christian Koennecke, Bruno-Marcel Mackert, Bob Siegerink, Heinrich J. Audebert, on behalf of the Berlin–SPecific Acute Treatment in Ischemic or hAemorrhagic Stroke With Long Term Follow-up (B-SPATIAL) registry
Neurology Sep 2022, 99 (13) e1335-e1344; DOI: 10.1212/WNL.0000000000200916

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
81

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 99 no. 13 e1335-e1344
DOI: 
https://doi.org/10.1212/WNL.0000000000200916
PubMed: 
35918161

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 4, 2021
  • Accepted in final form May 17, 2022
  • First Published August 2, 2022.

Article Versions

  • Previous version (August 2, 2022 - 12:45).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Ira Napierkowski, PhD*,
    2. Irina Lorenz-Meyer*,
    3. Annegret Hille, PHD,
    4. Martin Ebinger, MD, PhD,
    5. Erik Freitag,
    6. Peter Harmel, MD,
    7. Matthias Endres,
    8. Georg Hagemann, MD,
    9. Hans-Christian Koennecke, MD,
    10. Bruno-Marcel Mackert, MD,
    11. Bob Siegerink, PhD,
    12. Heinrich J. Audebert, MD;
    13. on behalf of the Berlin–SPecific Acute Treatment in Ischemic or hAemorrhagic Stroke With Long Term Follow-up (B-SPATIAL) registry
  1. Ira Napierkowski, PhD*,
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Irina Lorenz-Meyer*,
  4. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  5. Annegret Hille, PHD,
  6. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  7. Martin Ebinger, MD, PhD,
  8. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  9. Erik Freitag,
  10. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  11. Peter Harmel, MD,
  12. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  13. Matthias Endres,
  14. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  15. Georg Hagemann, MD,
  16. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  17. Hans-Christian Koennecke, MD,
  18. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  19. Bruno-Marcel Mackert, MD,
  20. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  21. Bob Siegerink, PhD,
  22. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  23. Heinrich J. Audebert, MD;
  24. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  25. on behalf of the Berlin–SPecific Acute Treatment in Ischemic or hAemorrhagic Stroke With Long Term Follow-up (B-SPATIAL) registry
  26. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  1. From the Center for Stroke Research Berlin (I.N., I.L.M, A.H., M.E., E.F., P.H., M.E., B.S., H.J.A.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Klinik für Neurologie (M.E.), Medical Park Berlin Humboldtmühle, Germany; Klinik und Hochschulambulanz für Neurologie (E.F., P.H., M.E.), Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; German Centre for Cardiovascular Research (DZHK) (M.E.), Partner Site Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Partner Site Berlin, Germany; NeuroCure Cluster of Excellence (M.E.), Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Helios Klinikum Berlin Buch (G.H.), Germany; Klinik für Neurologie Mit Stroke Unit (H.-C.K.); Vivantes Klinikum Im Friedrichshain, Berlin, Germany; Klinik für Neurologie Mit Stroke Unit (B.-M.M.), Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; and Department of Clinical Epidemiology (B.S.), Leiden University Medical Center, Leiden University, The Netherlands.
  1. Correspondence
    Dr. Audebert heinrich.audebert{at}charite.de
View Full Text

Article usage

Article usage: August 2022 to December 2022

AbstractFullPdfSource
Aug 2022389019Highwire
Sep 20224713832Highwire
Oct 20222391821Highwire
Nov 20227554Highwire
Dec 20225925Highwire

Cited By...

  • 3 Citations
  • Google Scholar

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Study Funding
    • Disclosure
    • Acknowledgment
    • Appendix 1 Authors
    • Appendix 2 Coinvestigators
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • The Opt-out Approach in Research to Benefit Public HealthIs “Opting Out” In?

Topics Discussed

  • All Cerebrovascular disease/Stroke
  • Clinical trials Methodology/study design
  • Outcome research
  • Critical care

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise